Alireza JavadzadehTabriz
Tabriz, Iran
NCT Number: NCT00817245
Etiology of ICSCR is not known however recent studies regard the role of immunologic and infectious processes in the pathogenesis of ICSCR.one of these hypothesis is the role of helicobacter pylori in the pathogenesis of ICSCR so perhaps treatment of h pylori have positive effect on the remission of ICSCR.
Looking for future studies?
Notify Me28 year–40 year
All sexes
Interventional
Phase 1 / Phase 2
Tabriz, Iran
we will choose 50 cases of patients with ICSCR who are infected with h.pylori.25 cases will receive anti h.pylori regiment and 25 cases as controls will receive no medication.then we will compare the time of submacular fluid resorption and macular thickness and visual acuity among these two groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
we will evaluate the effect of medication(anti h.pylori) on the remission of ICSCR
Other names: treatment of Central serous chorioretinopathy
Tabriz University
Other
Effect of Helicobacter Pylori Treatment on Remission of Idiopathic Central Serous Chorioretinopathy (ICSCR)
Acronym: ICSCR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05847049
Central Serous Chorioretinopathy, Eye Diseases
Cairo, Egypt
View Trial DetailsNCT04723160
Arterial Occlusive Diseases, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT05104138
Central Serous Chorioretinopathy, Eye Diseases
View Trial DetailsNCT04224831
Central Serous Chorioretinopathy, Chronic Central Serous Chorioretinopathy
Ankara, Türkiye, Turkey (Türkiye)
View Trial Details